SAIQA MUNEER

Dr. SAIQA MUNEER

Queensland University of Technology
+1
orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2017 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
GMGhulam Murtaza
Ghulam Murtaza
AKAbida Kalsoom Khan
Abida Kalsoom Khan
RRRehana Rashid
Rehana Rashid
SAIQA MUNEERSAIQA MUNEER
SAIQA MUNEER
SHSyed Muhammad Farid Hasan
Syed Muhammad Farid Hasan
JCJianxin Chen
Jianxin Chen
Several pathologies such as neurodegeneration and cancer are associated with aging, which is affected by many genetic and environmental factors. Healthy aging conceives human longevity, possibly due to carrying the defensive genes. For instance, FOXO (forkhead box O) genes determine human longevity. FOXO transcription factors are involved in the regulation of longevity phenomenon via insulin and insulin‐like growth factor signaling. Only one FOXO gene (FOXO DAF‐16) exists in invertebrates, while four FOXO genes, that is, FOXO1, FOXO3, FOXO4, and FOXO6 are found in mammals. These four transcription factors are involved in the multiple cellular pathways, which regulate growth, stress resistance, metabolism, cellular differentiation, and apoptosis in mammals. However, the accurate mode of longevity by FOXO factors is unclear until now. This article describes briefly the existing knowledge that is related to the role of FOXO factors in human longevity.

1 September 2020 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
SAIQA MUNEERSAIQA MUNEER
SAIQA MUNEER
TWTony Wang
Tony Wang
LRLlew Rintoul
Llew Rintoul
GAGodwin A. Ayoko
Godwin A. Ayoko
NINazrul Islam
Nazrul Islam
EIEmad L. Izake
Emad L. Izake

6 September 2020 in Nanomaterials
Verified
Journal Article
Open access
PDF file
SAIQA MUNEERSAIQA MUNEER
SAIQA MUNEER
DSDaniel Sarfo
Daniel Sarfo
GAGodwin Ayoko
Godwin Ayoko
NINazrul Islam
Nazrul Islam
Emad IzakeEmad Izake
Emad Izake
A sensitive and recyclable plasmonic nickel foam sensor has been developed for surface-enhanced Raman spectroscopy (SERS). A simple electrochemical method was used to deposit flower-shaped gold nanostructures onto nickel foam substrate. The high packing of the gold nanoflowers onto the nickel foam led to a high enhancement factor (EF) of 1.6 × 1011. The new SERS sensor was utilized for the direct determination of the broad-spectrum β-lactam carbapenem antibiotic meropenem in human blood plasma down to one pM. The sensor was also used in High Performance Liquid Chromatography (HPLC)-SERS assembly to provide fingerprint identification of meropenem in human blood plasma. Moreover, the SERS measurements were reproducible in aqueous solution and human blood plasma (RSD = 5.5%) and (RSD = 2.86%), respectively at 200 µg/mL (n = 3), and successfully recycled using a simple method, and hence, used for the repeated determination of the drug by SERS. Therefore, the new sensor has a strong potential to be applied for the therapeutic drug monitoring of meropenem at points of care and intensive care units.

16 February 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
SSShahjabeen Sharif
Shahjabeen Sharif
SAIQA MUNEERSAIQA MUNEER
SAIQA MUNEER
Emad IzakeEmad Izake
Emad Izake
NINazrul Islam
Nazrul Islam
This study investigated the development and characterization of leucine and magnesium stearate (MgSt) embedded wet milled inhalable ibuprofen (IBF) dry powder inhaler (DPI) formulations. IBF microparticles were prepared by a wet milling homogenization process and were characterized by SEM, FTIR, DSC, XRD and TGA. Using a Twin-Stage Impinger (TSI), the in vitro aerosolization of the formulations with and without carrier lactose was studied at a flow rate of 60± 5 L/min and the IBF was determined using a validated HPLC method. The flow properties were determined by the Carr’s Index (CI), Hausner Ratio (HR) and Angle of Repose (AR) of the milled IBF with 4–6.25% leucine and leucine containing formulations showed higher flow property than those of formulations without leucine. The fine particle fraction (FPF) of IBF from the prepared formulations was significantly (p = 0.000278) higher (37.1 ± 3.8%) compared to the original drug (FPF 3.7 ± 0.9%) owing to the presence of leucine, which enhanced the aerosolization of the milled IBF particles. Using quantitative phase analysis, the XPRD data revealed the crystallinity and accurate weight percentages of the milled IBF in the formulations. FTIR revealed no changes of the structural integrity of the milled IBF in presence of leucine or MgSt. The presence of 2.5% MgSt in the selected formulations produced the highest solubility (252.8 ± 0.6 µg/mL) of IBF compared to that of unmilled IBF (147.4 ± 1.6 µg/mL). The drug dissolution from all formulations containing 4–6.25% leucine showed 12.2–18.6% drug release in 2.5 min; however, 100% IBF dissolution occurred in 2 h whereas around 50% original and dry milled IBF dissolved in 2 h. The results indicated the successful preparation of inhalable IBF microparticles by the wet milling method and the developed DPI formulations with enhanced aerosolization and solubility due to the presence of leucine may be considered as future IBF formulations for inhalation.

21 September 2021 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
ARAbdur Rashid
Abdur Rashid
SAIQA MUNEERSAIQA MUNEER
SAIQA MUNEER
JMJayanti Mendhi
Jayanti Mendhi
MSMohammad Zaidur Rahman Sabuj
Mohammad Zaidur Rahman Sabuj
YAYahya Alhamhoom
Yahya Alhamhoom
NINazrul Islam
Nazrul Islam

1 February 2020 in Talanta
Verified
Journal Article
Closed access
SAIQA MUNEERSAIQA MUNEER
SAIQA MUNEER
GAGodwin A. Ayoko
Godwin A. Ayoko
NINazrul Islam
Nazrul Islam
Emad IzakeEmad Izake
Emad Izake